Drawing for ORAIOS

USPTO serial 78923685

ORAIOS

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
PARK, JENNY K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ORAIOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher N. Bolinger

CHRISTOPHER N BOLINGER PFIZER INC150 E 42ND ST # 150/5NEW YORK, NY 10017-5612UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the treatment of sleep diseases and disorders, gynecological diseases and disorders, cholesterol related diseases and disorders, cardiovascular diseases, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, viral disorders, and fungal disorders; pharmaceutical preparations, namely, smoking cessation preparations, dermatological preparations, preparations for the prevention and treatment of osteoporosis, and ophthalmological preparationsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 6, 2007MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Dec 6, 2007ABN5ABANDONMENT - AFTER PUBLICATION—
Dec 5, 2007EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 26, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 3, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 14, 2007NPUBNOTICE OF PUBLICATION—
Feb 15, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 15, 2007ALIEASSIGNED TO LIE—
Jan 11, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2007CNEAEXAMINERS AMENDMENT MAILED—
Jan 9, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Jan 9, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 8, 2006CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 8, 2006CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 6, 2006DOCKASSIGNED TO EXAMINER—
Jul 11, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance